The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Liposomal Drug-delivery System Market Research Report 2025
Synopsis
Liposomal Drug-delivery System is a pharmaceutical technology that encapsulates drugs within lipid-based vesicles called liposomes. These microscopic structures enhance the delivery of drugs to target tissues, improve drug stability, and control drug release rates. Liposomal drug delivery is used to enhance the therapeutic effects of medications, reduce side effects, and improve the solubility of poorly water-soluble drugs.
The global Liposomal Drug-delivery System market was valued at US$ 3328 million in 2023 and is anticipated to reach US$ 6503.3 million by 2030, witnessing a CAGR of 10.1% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Liposomal Drug-delivery System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liposomal Drug-delivery System.
Report Scope
The Liposomal Drug-delivery System market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Liposomal Drug-delivery System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Liposomal Drug-delivery System companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lipoid Kosmetik
Lucas Meyer Cosmetics
Nippon Fine Chemical
Enoc Solutions
Nanovec
Lipotec
Croda
H&A Pharmachem
Lipomize
ID bio
BioSpectrum
Derma Clinical
Kewpie Corporation
Nanohealth Biotech
Creative Biostructure
Phenbiox
NOF CORPORATION
KYOWA PHARMA CHEMICAL
Nikko Chemicals
Segment by Type
Liposome Vitamin
Liposome Ceramide
Liposome CoQ10
Others
Segment by Application
Medical
Cosmetics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Liposomal Drug-delivery System companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Liposomal Drug-delivery System is a pharmaceutical technology that encapsulates drugs within lipid-based vesicles called liposomes. These microscopic structures enhance the delivery of drugs to target tissues, improve drug stability, and control drug release rates. Liposomal drug delivery is used to enhance the therapeutic effects of medications, reduce side effects, and improve the solubility of poorly water-soluble drugs.
The global Liposomal Drug-delivery System market was valued at US$ 3328 million in 2023 and is anticipated to reach US$ 6503.3 million by 2030, witnessing a CAGR of 10.1% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Liposomal Drug-delivery System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liposomal Drug-delivery System.
Report Scope
The Liposomal Drug-delivery System market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Liposomal Drug-delivery System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Liposomal Drug-delivery System companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lipoid Kosmetik
Lucas Meyer Cosmetics
Nippon Fine Chemical
Enoc Solutions
Nanovec
Lipotec
Croda
H&A Pharmachem
Lipomize
ID bio
BioSpectrum
Derma Clinical
Kewpie Corporation
Nanohealth Biotech
Creative Biostructure
Phenbiox
NOF CORPORATION
KYOWA PHARMA CHEMICAL
Nikko Chemicals
Segment by Type
Liposome Vitamin
Liposome Ceramide
Liposome CoQ10
Others
Segment by Application
Medical
Cosmetics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Liposomal Drug-delivery System companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Liposomal Drug-delivery System Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Liposome Vitamin
1.2.3 Liposome Ceramide
1.2.4 Liposome CoQ10
1.2.5 Others
1.3 Market by Application
1.3.1 Global Liposomal Drug-delivery System Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Medical
1.3.3 Cosmetics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Liposomal Drug-delivery System Market Perspective (2019-2030)
2.2 Liposomal Drug-delivery System Growth Trends by Region
2.2.1 Global Liposomal Drug-delivery System Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Liposomal Drug-delivery System Historic Market Size by Region (2019-2024)
2.2.3 Liposomal Drug-delivery System Forecasted Market Size by Region (2025-2030)
2.3 Liposomal Drug-delivery System Market Dynamics
2.3.1 Liposomal Drug-delivery System Industry Trends
2.3.2 Liposomal Drug-delivery System Market Drivers
2.3.3 Liposomal Drug-delivery System Market Challenges
2.3.4 Liposomal Drug-delivery System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Liposomal Drug-delivery System Players by Revenue
3.1.1 Global Top Liposomal Drug-delivery System Players by Revenue (2019-2024)
3.1.2 Global Liposomal Drug-delivery System Revenue Market Share by Players (2019-2024)
3.2 Global Liposomal Drug-delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Liposomal Drug-delivery System Revenue
3.4 Global Liposomal Drug-delivery System Market Concentration Ratio
3.4.1 Global Liposomal Drug-delivery System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Liposomal Drug-delivery System Revenue in 2023
3.5 Liposomal Drug-delivery System Key Players Head office and Area Served
3.6 Key Players Liposomal Drug-delivery System Product Solution and Service
3.7 Date of Enter into Liposomal Drug-delivery System Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Liposomal Drug-delivery System Breakdown Data by Type
4.1 Global Liposomal Drug-delivery System Historic Market Size by Type (2019-2024)
4.2 Global Liposomal Drug-delivery System Forecasted Market Size by Type (2025-2030)
5 Liposomal Drug-delivery System Breakdown Data by Application
5.1 Global Liposomal Drug-delivery System Historic Market Size by Application (2019-2024)
5.2 Global Liposomal Drug-delivery System Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Liposomal Drug-delivery System Market Size (2019-2030)
6.2 North America Liposomal Drug-delivery System Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Liposomal Drug-delivery System Market Size by Country (2019-2024)
6.4 North America Liposomal Drug-delivery System Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Liposomal Drug-delivery System Market Size (2019-2030)
7.2 Europe Liposomal Drug-delivery System Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Liposomal Drug-delivery System Market Size by Country (2019-2024)
7.4 Europe Liposomal Drug-delivery System Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Liposomal Drug-delivery System Market Size (2019-2030)
8.2 Asia-Pacific Liposomal Drug-delivery System Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Liposomal Drug-delivery System Market Size by Region (2019-2024)
8.4 Asia-Pacific Liposomal Drug-delivery System Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Liposomal Drug-delivery System Market Size (2019-2030)
9.2 Latin America Liposomal Drug-delivery System Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Liposomal Drug-delivery System Market Size by Country (2019-2024)
9.4 Latin America Liposomal Drug-delivery System Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Liposomal Drug-delivery System Market Size (2019-2030)
10.2 Middle East & Africa Liposomal Drug-delivery System Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Liposomal Drug-delivery System Market Size by Country (2019-2024)
10.4 Middle East & Africa Liposomal Drug-delivery System Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lipoid Kosmetik
11.1.1 Lipoid Kosmetik Company Detail
11.1.2 Lipoid Kosmetik Business Overview
11.1.3 Lipoid Kosmetik Liposomal Drug-delivery System Introduction
11.1.4 Lipoid Kosmetik Revenue in Liposomal Drug-delivery System Business (2019-2024)
11.1.5 Lipoid Kosmetik Recent Development
11.2 Lucas Meyer Cosmetics
11.2.1 Lucas Meyer Cosmetics Company Detail
11.2.2 Lucas Meyer Cosmetics Business Overview
11.2.3 Lucas Meyer Cosmetics Liposomal Drug-delivery System Introduction
11.2.4 Lucas Meyer Cosmetics Revenue in Liposomal Drug-delivery System Business (2019-2024)
11.2.5 Lucas Meyer Cosmetics Recent Development
11.3 Nippon Fine Chemical
11.3.1 Nippon Fine Chemical Company Detail
11.3.2 Nippon Fine Chemical Business Overview
11.3.3 Nippon Fine Chemical Liposomal Drug-delivery System Introduction
11.3.4 Nippon Fine Chemical Revenue in Liposomal Drug-delivery System Business (2019-2024)
11.3.5 Nippon Fine Chemical Recent Development
11.4 Enoc Solutions
11.4.1 Enoc Solutions Company Detail
11.4.2 Enoc Solutions Business Overview
11.4.3 Enoc Solutions Liposomal Drug-delivery System Introduction
11.4.4 Enoc Solutions Revenue in Liposomal Drug-delivery System Business (2019-2024)
11.4.5 Enoc Solutions Recent Development
11.5 Nanovec
11.5.1 Nanovec Company Detail
11.5.2 Nanovec Business Overview
11.5.3 Nanovec Liposomal Drug-delivery System Introduction
11.5.4 Nanovec Revenue in Liposomal Drug-delivery System Business (2019-2024)
11.5.5 Nanovec Recent Development
11.6 Lipotec
11.6.1 Lipotec Company Detail
11.6.2 Lipotec Business Overview
11.6.3 Lipotec Liposomal Drug-delivery System Introduction
11.6.4 Lipotec Revenue in Liposomal Drug-delivery System Business (2019-2024)
11.6.5 Lipotec Recent Development
11.7 Croda
11.7.1 Croda Company Detail
11.7.2 Croda Business Overview
11.7.3 Croda Liposomal Drug-delivery System Introduction
11.7.4 Croda Revenue in Liposomal Drug-delivery System Business (2019-2024)
11.7.5 Croda Recent Development
11.8 H&A Pharmachem
11.8.1 H&A Pharmachem Company Detail
11.8.2 H&A Pharmachem Business Overview
11.8.3 H&A Pharmachem Liposomal Drug-delivery System Introduction
11.8.4 H&A Pharmachem Revenue in Liposomal Drug-delivery System Business (2019-2024)
11.8.5 H&A Pharmachem Recent Development
11.9 Lipomize
11.9.1 Lipomize Company Detail
11.9.2 Lipomize Business Overview
11.9.3 Lipomize Liposomal Drug-delivery System Introduction
11.9.4 Lipomize Revenue in Liposomal Drug-delivery System Business (2019-2024)
11.9.5 Lipomize Recent Development
11.10 ID bio
11.10.1 ID bio Company Detail
11.10.2 ID bio Business Overview
11.10.3 ID bio Liposomal Drug-delivery System Introduction
11.10.4 ID bio Revenue in Liposomal Drug-delivery System Business (2019-2024)
11.10.5 ID bio Recent Development
11.11 BioSpectrum
11.11.1 BioSpectrum Company Detail
11.11.2 BioSpectrum Business Overview
11.11.3 BioSpectrum Liposomal Drug-delivery System Introduction
11.11.4 BioSpectrum Revenue in Liposomal Drug-delivery System Business (2019-2024)
11.11.5 BioSpectrum Recent Development
11.12 Derma Clinical
11.12.1 Derma Clinical Company Detail
11.12.2 Derma Clinical Business Overview
11.12.3 Derma Clinical Liposomal Drug-delivery System Introduction
11.12.4 Derma Clinical Revenue in Liposomal Drug-delivery System Business (2019-2024)
11.12.5 Derma Clinical Recent Development
11.13 Kewpie Corporation
11.13.1 Kewpie Corporation Company Detail
11.13.2 Kewpie Corporation Business Overview
11.13.3 Kewpie Corporation Liposomal Drug-delivery System Introduction
11.13.4 Kewpie Corporation Revenue in Liposomal Drug-delivery System Business (2019-2024)
11.13.5 Kewpie Corporation Recent Development
11.14 Nanohealth Biotech
11.14.1 Nanohealth Biotech Company Detail
11.14.2 Nanohealth Biotech Business Overview
11.14.3 Nanohealth Biotech Liposomal Drug-delivery System Introduction
11.14.4 Nanohealth Biotech Revenue in Liposomal Drug-delivery System Business (2019-2024)
11.14.5 Nanohealth Biotech Recent Development
11.15 Creative Biostructure
11.15.1 Creative Biostructure Company Detail
11.15.2 Creative Biostructure Business Overview
11.15.3 Creative Biostructure Liposomal Drug-delivery System Introduction
11.15.4 Creative Biostructure Revenue in Liposomal Drug-delivery System Business (2019-2024)
11.15.5 Creative Biostructure Recent Development
11.16 Phenbiox
11.16.1 Phenbiox Company Detail
11.16.2 Phenbiox Business Overview
11.16.3 Phenbiox Liposomal Drug-delivery System Introduction
11.16.4 Phenbiox Revenue in Liposomal Drug-delivery System Business (2019-2024)
11.16.5 Phenbiox Recent Development
11.17 NOF CORPORATION
11.17.1 NOF CORPORATION Company Detail
11.17.2 NOF CORPORATION Business Overview
11.17.3 NOF CORPORATION Liposomal Drug-delivery System Introduction
11.17.4 NOF CORPORATION Revenue in Liposomal Drug-delivery System Business (2019-2024)
11.17.5 NOF CORPORATION Recent Development
11.18 KYOWA PHARMA CHEMICAL
11.18.1 KYOWA PHARMA CHEMICAL Company Detail
11.18.2 KYOWA PHARMA CHEMICAL Business Overview
11.18.3 KYOWA PHARMA CHEMICAL Liposomal Drug-delivery System Introduction
11.18.4 KYOWA PHARMA CHEMICAL Revenue in Liposomal Drug-delivery System Business (2019-2024)
11.18.5 KYOWA PHARMA CHEMICAL Recent Development
11.19 Nikko Chemicals
11.19.1 Nikko Chemicals Company Detail
11.19.2 Nikko Chemicals Business Overview
11.19.3 Nikko Chemicals Liposomal Drug-delivery System Introduction
11.19.4 Nikko Chemicals Revenue in Liposomal Drug-delivery System Business (2019-2024)
11.19.5 Nikko Chemicals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Liposomal Drug-delivery System Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Liposome Vitamin
Table 3. Key Players of Liposome Ceramide
Table 4. Key Players of Liposome CoQ10
Table 5. Key Players of Others
Table 6. Global Liposomal Drug-delivery System Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Liposomal Drug-delivery System Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Liposomal Drug-delivery System Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Liposomal Drug-delivery System Market Share by Region (2019-2024)
Table 10. Global Liposomal Drug-delivery System Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Liposomal Drug-delivery System Market Share by Region (2025-2030)
Table 12. Liposomal Drug-delivery System Market Trends
Table 13. Liposomal Drug-delivery System Market Drivers
Table 14. Liposomal Drug-delivery System Market Challenges
Table 15. Liposomal Drug-delivery System Market Restraints
Table 16. Global Liposomal Drug-delivery System Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Liposomal Drug-delivery System Market Share by Players (2019-2024)
Table 18. Global Top Liposomal Drug-delivery System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposomal Drug-delivery System as of 2023)
Table 19. Ranking of Global Top Liposomal Drug-delivery System Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Liposomal Drug-delivery System Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Liposomal Drug-delivery System Product Solution and Service
Table 23. Date of Enter into Liposomal Drug-delivery System Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Liposomal Drug-delivery System Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Liposomal Drug-delivery System Revenue Market Share by Type (2019-2024)
Table 27. Global Liposomal Drug-delivery System Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Liposomal Drug-delivery System Revenue Market Share by Type (2025-2030)
Table 29. Global Liposomal Drug-delivery System Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Liposomal Drug-delivery System Revenue Market Share by Application (2019-2024)
Table 31. Global Liposomal Drug-delivery System Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Liposomal Drug-delivery System Revenue Market Share by Application (2025-2030)
Table 33. North America Liposomal Drug-delivery System Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Liposomal Drug-delivery System Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Liposomal Drug-delivery System Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Liposomal Drug-delivery System Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Liposomal Drug-delivery System Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Liposomal Drug-delivery System Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Liposomal Drug-delivery System Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Liposomal Drug-delivery System Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Liposomal Drug-delivery System Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Liposomal Drug-delivery System Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Liposomal Drug-delivery System Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Liposomal Drug-delivery System Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Liposomal Drug-delivery System Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Liposomal Drug-delivery System Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Liposomal Drug-delivery System Market Size by Country (2025-2030) & (US$ Million)
Table 48. Lipoid Kosmetik Company Detail
Table 49. Lipoid Kosmetik Business Overview
Table 50. Lipoid Kosmetik Liposomal Drug-delivery System Product
Table 51. Lipoid Kosmetik Revenue in Liposomal Drug-delivery System Business (2019-2024) & (US$ Million)
Table 52. Lipoid Kosmetik Recent Development
Table 53. Lucas Meyer Cosmetics Company Detail
Table 54. Lucas Meyer Cosmetics Business Overview
Table 55. Lucas Meyer Cosmetics Liposomal Drug-delivery System Product
Table 56. Lucas Meyer Cosmetics Revenue in Liposomal Drug-delivery System Business (2019-2024) & (US$ Million)
Table 57. Lucas Meyer Cosmetics Recent Development
Table 58. Nippon Fine Chemical Company Detail
Table 59. Nippon Fine Chemical Business Overview
Table 60. Nippon Fine Chemical Liposomal Drug-delivery System Product
Table 61. Nippon Fine Chemical Revenue in Liposomal Drug-delivery System Business (2019-2024) & (US$ Million)
Table 62. Nippon Fine Chemical Recent Development
Table 63. Enoc Solutions Company Detail
Table 64. Enoc Solutions Business Overview
Table 65. Enoc Solutions Liposomal Drug-delivery System Product
Table 66. Enoc Solutions Revenue in Liposomal Drug-delivery System Business (2019-2024) & (US$ Million)
Table 67. Enoc Solutions Recent Development
Table 68. Nanovec Company Detail
Table 69. Nanovec Business Overview
Table 70. Nanovec Liposomal Drug-delivery System Product
Table 71. Nanovec Revenue in Liposomal Drug-delivery System Business (2019-2024) & (US$ Million)
Table 72. Nanovec Recent Development
Table 73. Lipotec Company Detail
Table 74. Lipotec Business Overview
Table 75. Lipotec Liposomal Drug-delivery System Product
Table 76. Lipotec Revenue in Liposomal Drug-delivery System Business (2019-2024) & (US$ Million)
Table 77. Lipotec Recent Development
Table 78. Croda Company Detail
Table 79. Croda Business Overview
Table 80. Croda Liposomal Drug-delivery System Product
Table 81. Croda Revenue in Liposomal Drug-delivery System Business (2019-2024) & (US$ Million)
Table 82. Croda Recent Development
Table 83. H&A Pharmachem Company Detail
Table 84. H&A Pharmachem Business Overview
Table 85. H&A Pharmachem Liposomal Drug-delivery System Product
Table 86. H&A Pharmachem Revenue in Liposomal Drug-delivery System Business (2019-2024) & (US$ Million)
Table 87. H&A Pharmachem Recent Development
Table 88. Lipomize Company Detail
Table 89. Lipomize Business Overview
Table 90. Lipomize Liposomal Drug-delivery System Product
Table 91. Lipomize Revenue in Liposomal Drug-delivery System Business (2019-2024) & (US$ Million)
Table 92. Lipomize Recent Development
Table 93. ID bio Company Detail
Table 94. ID bio Business Overview
Table 95. ID bio Liposomal Drug-delivery System Product
Table 96. ID bio Revenue in Liposomal Drug-delivery System Business (2019-2024) & (US$ Million)
Table 97. ID bio Recent Development
Table 98. BioSpectrum Company Detail
Table 99. BioSpectrum Business Overview
Table 100. BioSpectrum Liposomal Drug-delivery System Product
Table 101. BioSpectrum Revenue in Liposomal Drug-delivery System Business (2019-2024) & (US$ Million)
Table 102. BioSpectrum Recent Development
Table 103. Derma Clinical Company Detail
Table 104. Derma Clinical Business Overview
Table 105. Derma Clinical Liposomal Drug-delivery System Product
Table 106. Derma Clinical Revenue in Liposomal Drug-delivery System Business (2019-2024) & (US$ Million)
Table 107. Derma Clinical Recent Development
Table 108. Kewpie Corporation Company Detail
Table 109. Kewpie Corporation Business Overview
Table 110. Kewpie Corporation Liposomal Drug-delivery System Product
Table 111. Kewpie Corporation Revenue in Liposomal Drug-delivery System Business (2019-2024) & (US$ Million)
Table 112. Kewpie Corporation Recent Development
Table 113. Nanohealth Biotech Company Detail
Table 114. Nanohealth Biotech Business Overview
Table 115. Nanohealth Biotech Liposomal Drug-delivery System Product
Table 116. Nanohealth Biotech Revenue in Liposomal Drug-delivery System Business (2019-2024) & (US$ Million)
Table 117. Nanohealth Biotech Recent Development
Table 118. Creative Biostructure Company Detail
Table 119. Creative Biostructure Business Overview
Table 120. Creative Biostructure Liposomal Drug-delivery System Product
Table 121. Creative Biostructure Revenue in Liposomal Drug-delivery System Business (2019-2024) & (US$ Million)
Table 122. Creative Biostructure Recent Development
Table 123. Phenbiox Company Detail
Table 124. Phenbiox Business Overview
Table 125. Phenbiox Liposomal Drug-delivery System Product
Table 126. Phenbiox Revenue in Liposomal Drug-delivery System Business (2019-2024) & (US$ Million)
Table 127. Phenbiox Recent Development
Table 128. NOF CORPORATION Company Detail
Table 129. NOF CORPORATION Business Overview
Table 130. NOF CORPORATION Liposomal Drug-delivery System Product
Table 131. NOF CORPORATION Revenue in Liposomal Drug-delivery System Business (2019-2024) & (US$ Million)
Table 132. NOF CORPORATION Recent Development
Table 133. KYOWA PHARMA CHEMICAL Company Detail
Table 134. KYOWA PHARMA CHEMICAL Business Overview
Table 135. KYOWA PHARMA CHEMICAL Liposomal Drug-delivery System Product
Table 136. KYOWA PHARMA CHEMICAL Revenue in Liposomal Drug-delivery System Business (2019-2024) & (US$ Million)
Table 137. KYOWA PHARMA CHEMICAL Recent Development
Table 138. Nikko Chemicals Company Detail
Table 139. Nikko Chemicals Business Overview
Table 140. Nikko Chemicals Liposomal Drug-delivery System Product
Table 141. Nikko Chemicals Revenue in Liposomal Drug-delivery System Business (2019-2024) & (US$ Million)
Table 142. Nikko Chemicals Recent Development
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Liposomal Drug-delivery System Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Liposomal Drug-delivery System Market Share by Type: 2023 VS 2030
Figure 3. Liposome Vitamin Features
Figure 4. Liposome Ceramide Features
Figure 5. Liposome CoQ10 Features
Figure 6. Others Features
Figure 7. Global Liposomal Drug-delivery System Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Liposomal Drug-delivery System Market Share by Application: 2023 VS 2030
Figure 9. Medical Case Studies
Figure 10. Cosmetics Case Studies
Figure 11. Liposomal Drug-delivery System Report Years Considered
Figure 12. Global Liposomal Drug-delivery System Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Liposomal Drug-delivery System Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Liposomal Drug-delivery System Market Share by Region: 2023 VS 2030
Figure 15. Global Liposomal Drug-delivery System Market Share by Players in 2023
Figure 16. Global Top Liposomal Drug-delivery System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposomal Drug-delivery System as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Liposomal Drug-delivery System Revenue in 2023
Figure 18. North America Liposomal Drug-delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Liposomal Drug-delivery System Market Share by Country (2019-2030)
Figure 20. United States Liposomal Drug-delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Liposomal Drug-delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Liposomal Drug-delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Liposomal Drug-delivery System Market Share by Country (2019-2030)
Figure 24. Germany Liposomal Drug-delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Liposomal Drug-delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Liposomal Drug-delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Liposomal Drug-delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Liposomal Drug-delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Liposomal Drug-delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Liposomal Drug-delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Liposomal Drug-delivery System Market Share by Region (2019-2030)
Figure 32. China Liposomal Drug-delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Liposomal Drug-delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Liposomal Drug-delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Liposomal Drug-delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Liposomal Drug-delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Liposomal Drug-delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Liposomal Drug-delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Liposomal Drug-delivery System Market Share by Country (2019-2030)
Figure 40. Mexico Liposomal Drug-delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Liposomal Drug-delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Liposomal Drug-delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Liposomal Drug-delivery System Market Share by Country (2019-2030)
Figure 44. Turkey Liposomal Drug-delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Liposomal Drug-delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Lipoid Kosmetik Revenue Growth Rate in Liposomal Drug-delivery System Business (2019-2024)
Figure 47. Lucas Meyer Cosmetics Revenue Growth Rate in Liposomal Drug-delivery System Business (2019-2024)
Figure 48. Nippon Fine Chemical Revenue Growth Rate in Liposomal Drug-delivery System Business (2019-2024)
Figure 49. Enoc Solutions Revenue Growth Rate in Liposomal Drug-delivery System Business (2019-2024)
Figure 50. Nanovec Revenue Growth Rate in Liposomal Drug-delivery System Business (2019-2024)
Figure 51. Lipotec Revenue Growth Rate in Liposomal Drug-delivery System Business (2019-2024)
Figure 52. Croda Revenue Growth Rate in Liposomal Drug-delivery System Business (2019-2024)
Figure 53. H&A Pharmachem Revenue Growth Rate in Liposomal Drug-delivery System Business (2019-2024)
Figure 54. Lipomize Revenue Growth Rate in Liposomal Drug-delivery System Business (2019-2024)
Figure 55. ID bio Revenue Growth Rate in Liposomal Drug-delivery System Business (2019-2024)
Figure 56. BioSpectrum Revenue Growth Rate in Liposomal Drug-delivery System Business (2019-2024)
Figure 57. Derma Clinical Revenue Growth Rate in Liposomal Drug-delivery System Business (2019-2024)
Figure 58. Kewpie Corporation Revenue Growth Rate in Liposomal Drug-delivery System Business (2019-2024)
Figure 59. Nanohealth Biotech Revenue Growth Rate in Liposomal Drug-delivery System Business (2019-2024)
Figure 60. Creative Biostructure Revenue Growth Rate in Liposomal Drug-delivery System Business (2019-2024)
Figure 61. Phenbiox Revenue Growth Rate in Liposomal Drug-delivery System Business (2019-2024)
Figure 62. NOF CORPORATION Revenue Growth Rate in Liposomal Drug-delivery System Business (2019-2024)
Figure 63. KYOWA PHARMA CHEMICAL Revenue Growth Rate in Liposomal Drug-delivery System Business (2019-2024)
Figure 64. Nikko Chemicals Revenue Growth Rate in Liposomal Drug-delivery System Business (2019-2024)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
